Latest filing published 24 Aug 2026 for Ovid Therapeutics Inc., €779k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Jeffrey A. Rona on record concern Ovid Therapeutics Inc. In total, 2 filings cover trades dated from 14 August 2026 to 24 August 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 24 August 2026, reports a transaction of €779k in Ovid Therapeutics Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations